Abdulla A. Damluji/Linkedin
Aug 12, 2025, 20:14
JACC Meta-Analysis: Anticoagulant Therapy for Atrial Fibrillation Patients Surviving Intracranial Hemorrhage
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials: JACCJournals.
New publication from our HeartWise research Group led by friend: Michael Nanna in JACC today!”
Read the full article here.
Title: Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage
Authors: Kuan-Yu Chi, Yu Chang, Pei-Lun Lee, Raiza Rossi, Yu-Shiuan Lin, Zafer Akman, Dimitrios Varrias, Abdulla A. Damluji, and Michael G. Nanna
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD